PLAB vs ICHR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

PLAB

43.1
AI Score
VS
PLAB Wins

ICHR

43.0
AI Score

Investment Advisor Scores

PLAB

43score
Recommendation
HOLD

ICHR

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PLAB ICHR Winner
Forward P/E 13.2626 17.2414 PLAB
PEG Ratio 2.6419 0.2465 ICHR
Revenue Growth 2.7% 22.7% ICHR
Earnings Growth 25.6% -6.1% PLAB
Tradestie Score 43.1/100 43.0/100 PLAB
Profit Margin 19.1% -4.0% PLAB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PLAB 1M: +13.0% · 3M: +7.8% ICHR 1M: +19.6% · 3M: -34.2%

Current Technical Phase

PLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 60.8 · Price: $31.49

ICHR

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.0 · Price: $62.92

Fundamentals Snapshot

Metric PLAB ICHR
Market Cap — —
Forward P/E 15.2 19.3
Trailing P/E 11.0 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin 0.3% 0.1%
Operating Margin 0.2% 0.0%
EPS 2.81 -1.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PLAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.